10 years of tamoxifen better to prevent breast cancer, study finds

Women using tamoxifen to prevent a recurrence of breast cancer had better protection if they took the drug for 10 years instead of the standard five, Oxford University researchers reported in The Lancet. Breast cancer experts said the data, which showed a lower recurrence rate among women who took the drug longer, also may have implications for postmenopausal women who usually take other medications to prevent a recurrence.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Claims
Meridian Health Plan
Detroit, MI
Sr. Analyst-Healthcare
BJC HealthCare
Saint Louis, MO
Regulatory Senior Managing/Principal Engineer/Scientist
Exponent
Menlo Park, CA
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI